Pawde DM, Viswanadh MK, Mehata AK, Sonkar R, Narendra, Poddar S, et al. Mannose receptor targeted bioadhesive chitosan nanoparticles of clofazimine for effective therapy of tuberculosis. Saudi Pharm J. 2020;28(12):1616–25.
Article
CAS
Google Scholar
Guerrero-Bustamante CA, Dedrick RM, Garlena RA, Russell DA, Hatfull GF. Toward a phage cocktail for tuberculosis: susceptibility and tuberculocidal action of mycobacteriophages against diverse Mycobacterium tuberculosis strains. MBio. 2021;12(3): e00973-21.
Article
Google Scholar
Azimi T, Mosadegh M, Nasiri MJ, Sabour S, Karimaei S, Nasser A. Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review. Infect Drug Resist. 2019;17(12):2943–59.
Article
Google Scholar
Hjort K, Jurén P, Toro JC, Hoffner S, Andersson DI, Sandegren L. Dynamics of extensive drug resistance evolution of Mycobacterium tuberculosis in a single patient during 9 years of disease and treatment. J Infect Dis. 2022;225(6):1011–20.
Article
CAS
Google Scholar
Khawbung JL, Nath D, Chakraborty S. Drug resistant tuberculosis: a review. Comp Immunol Microbiol Infect Dis. 2021;74: 101574.
Article
CAS
Google Scholar
Jiang Z, Wei J, Liang Y, Peng N, Li Y. Aminoglycoside antibiotics inhibit mycobacteriophage infection. Antibiotics. 2020;9(10):714.
Article
CAS
Google Scholar
Wei SH, Yu-xian SU, Li-jie ZH, Shi-heng XI, Jing-tao GA, Yu-hong LI. Tuberculosis research and innovation: interpretation of the WHO global tuberculosis report 2021. Chin J Antituberc. 2022;44(1):45.
Google Scholar
Garcia-Vilanova A, Chan J, Torrelles JB. Underestimated manipulative roles of Mycobacterium tuberculosis cell envelope glycolipids during infection. Front Immunol. 2019;18(10):2909.
Article
Google Scholar
Maitra A, Munshi T, Healy J, Martin LT, Vollmer W, Keep NH, et al. Cell wall peptidoglycan in Mycobacterium tuberculosis: an Achilles’ heel for the TB-causing pathogen. FEMS Microbiol Rev. 2019;43(5):548–75.
Article
CAS
Google Scholar
World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization; 2020. https://apps.who.int/iris/handle/10665/336069. Accessed 28 Nov 2022.
Zaman K. Tuberculosis: a global health problem. J Health Popul Nutr. 2010;28(2):111–3.
Article
CAS
Google Scholar
Starshinova A, Dovgalyk I, Belyaeva E, Glushkova A, Osipov N, Kudlay D. Efficacy of tuberculosis treatment in patients with drug-resistant tuberculosis with the use of bedaquiline: the experience of the Russian Federation. Antibiotics. 2022;11(11):1622.
Article
CAS
Google Scholar
Velayati AA, Masjedi MR, Farnia P, Tabarsi P, Ghanavi J, ZiaZarifi AH, et al. Emergence of new forms of totally drug-resistant tuberculosis bacilli. Chest. 2009;136(2):420–5.
Article
Google Scholar
Loewenberg S. India reports cases of totally drug-resistant tuberculosis. Lancet. 2012;379(9812):205.
Article
Google Scholar
Parida SK, Axelsson-Robertson R, Rao MV, Singh N, Master I, Lutckii A, et al. Totally drug-resistant tuberculosis and adjunct therapies. J Intern Med. 2015;277(4):388–405.
Article
CAS
Google Scholar
Lange C, Chesov D, Heyckendorf J, Leung CC, Udwadia Z, Dheda K. Drug-resistant tuberculosis: an update on disease burden, diagnosis and treatment: drug-resistant tuberculosis. Respirology. 2018;23(7):656–73.
Article
Google Scholar
Wang JL, Yin QY, Han C, Liu FL, Wang MS. Risk factors for death in tuberculosis patients requiring ICU care. Epidemiol Infect. 2021;149: e22.
Article
Google Scholar
Paleckyte A, Dissanayake O, Mpagama S, Lipman MC, McHugh TD. Reducing the risk of tuberculosis transmission for HCWs in high incidence settings. Antimicrob Resist Infect Control. 2021;10(1):106.
Article
Google Scholar
Mohidem NA, Hashim Z, Osman M, Muharam FM, Elias SM, Shaharudin R. Environment as the risk factor for tuberculosis in Malaysia: a systematic review of the literature. Rev Environ Health. 2021;36(4):493–9.
Article
Google Scholar
Angkwanish T, Vernooij HJCM, Sirimalaisuwan A, Charernpan P, Nielen M, Rutten VPMG. Prevalence and demographic risk factors of Mycobacterium tuberculosis infections in captive Asian elephants (Elephas maximus) based on serological assays. Front Vet Sci. 2021;2(8): 713663.
Article
Google Scholar
Varshney K, Anaele B, Molaei M, Frasso R, Maio V. Risk factors for poor outcomes among patients with extensively drug-resistant tuberculosis (XDR-TB): a scoping review. IDR. 2021;14:5429–48.
Article
Google Scholar
Flor de Lima B, Tavares M. Risk factors for extensively drug-resistant tuberculosis: a review. Clin Respir J. 2014;8(1):11–23.
Article
Google Scholar
Alam CM, Iqbal A, Sharma A, Schulman AH, Ali S. Microsatellite diversity, complexity, and host range of mycobacteriophage genomes of the Siphoviridae family. Front Genet. 2019;14(10):207.
Article
Google Scholar
Pope WH, Bowman CA, Russell DA, Jacobs-Sera D, Asai DJ, Cresawn SG, et al. Whole genome comparison of a large collection of mycobacteriophages reveals a continuum of phage genetic diversity. Elife. 2015;4: e06416.
Article
Google Scholar
Allué-Guardia A, Saranathan R, Chan J, Torrelles JB. Mycobacteriophages as potential therapeutic agents against drug-resistant tuberculosis. IJMS. 2021;22(2):735.
Article
Google Scholar
Hatfull GF. Molecular genetics of mycobacteriophages. Microbiol Spectr. 2014;2(2):1–36.
Article
Google Scholar
Gan Y, Liu P, Wu T, Guo S. Different characteristics between mycobacteriophage Chy1 and D29, which were classified as cluster A2 mycobacteriophages. Indian J Med Microbiol. 2016;34(2):186–92.
Article
CAS
Google Scholar
NdongmoTeytsa HM, Tsanou B, Bowong S, Lubuma JMS. Bifurcation analysis of a phage-bacteria interaction model with prophage induction. Math Med Biol J IMA. 2021;38(1):28–58.
Article
CAS
Google Scholar
Voigt E, Rall BC, Chatzinotas A, Brose U, Rosenbaum B. Phage strategies facilitate bacterial coexistence under environmental variability. PeerJ. 2021;4(9): e12194.
Article
Google Scholar
Doekes HM, Mulder GA, Hermsen R. Repeated outbreaks drive the evolution of bacteriophage communication. Elife. 2021;10: e58410.
Article
CAS
Google Scholar
Clokie MRJ, Millard AD, Letarov AV, Heaphy S. Phages in nature. Bacteriophage. 2011;1(1):31–45.
Article
Google Scholar
Siringan P, Connerton PL, Cummings NJ, Connerton IF. Alternative bacteriophage life cycles: the carrier state of Campylobacter jejuni. Open Biol. 2014;4(3): 130200.
Article
Google Scholar
Bajpai U, Mehta AK, Eniyan K, Sinha A, Ray A, Virdi S, et al. Isolation and characterization of bacteriophages from India, with lytic activity against Mycobacterium tuberculosis. Can J Microbiol. 2018;64(7):483–91.
Article
CAS
Google Scholar
Bebeacua C, Lai L, Vegge CS, Brøndsted L, van Heel M, Veesler D, et al. Visualizing a complete Siphoviridae member by single-particle electron microscopy: the structure of lactococcal phage TP901-1. J Virol. 2013;87(2):1061–8.
Article
CAS
Google Scholar
Mayer O, Jain P, Weisbrod TR, Biro D, Ho L, Jacobs-Sera D, et al. Fluorescent reporter DS6A mycobacteriophages reveal unique variations in infectibility and phage production in mycobacteria. J Bacteriol. 2016;198(23):3220–32.
Article
CAS
Google Scholar
Dedrick RM, Guerrero Bustamante CA, Garlena RA, Pinches RS, Cornely K, Hatfull GF. Mycobacteriophage ZoeJ: a broad host-range close relative of mycobacteriophage TM4. Tuberculosis. 2019;115:14–23.
Article
CAS
Google Scholar
Guo S, Ao Z. Phage in the diagnosis and treatment of tuberculosis. Front Biosci. 2012;17(7):2691–7.
Article
Google Scholar
Cahill J, Young R. Phage lysis: multiple genes for multiple barriers. In: Advances in virus research. Elsevier; 2019. p. 33–70. https://linkinghub.elsevier.com/retrieve/pii/S0065352718300563. Accessed 28 Nov 2022.
Li X, Zhang C, Wei F, Yu F, Zhao Z. Bactericidal activity of a holin-endolysin system derived from Vibrio alginolyticus phage HH109. Microb Pathog. 2021;159: 105135.
Article
CAS
Google Scholar
Wu Z, Zhang Y, Xu X, Ahmed T, Yang Y, Loh B, et al. The holin-endolysin lysis system of the OP2-like phage X2 infecting Xanthomonas oryzae pv. oryzae. Viruses. 2021;13(10):1949.
Article
CAS
Google Scholar
Xu H, Bao X, Hong W, Wang A, Wang K, Dong H, et al. Biological characterization and evolution of bacteriophage T7-△holin during the serial passage process. Front Microbiol. 2021;2(12): 705310.
Article
Google Scholar
Zhou B, Wu Y, Su Z. Computational simulation of holin S105 in membrane bilayer and its dimerization through a helix-turn-helix motif. J Membr Biol. 2021;254(4):397–407.
Article
CAS
Google Scholar
Fraga AG, Trigo G, Murthy RK, Akhtar S, Hebbur M, Pacheco AR, et al. Antimicrobial activity of mycobacteriophage D29 lysin b during Mycobacterium ulcerans infection. PLoS Negl Trop Dis. 2019;13(8): e0007113.
Article
Google Scholar
Pohane AA, Joshi H, Jain V. Molecular dissection of phage endolysin. J Biol Chem. 2014;289(17):12085–95.
Article
CAS
Google Scholar
Catalão M, Pimentel M. Mycobacteriophage lysis enzymes: targeting the mycobacterial cell envelope. Viruses. 2018;10(8):428.
Article
Google Scholar
Bajpai U, Mehta AK, Eniyan K, Sinha A, Ray A, Virdi S, et al. Correction: Isolation and characterization of bacteriophages from India, with lytic activity against Mycobacterium tuberculosis. Can J Microbiol. 2020;66(7):455–455.
Article
CAS
Google Scholar
de Leeuw M, Baron M, Ben David O, Kushmaro A. Molecular insights into bacteriophage evolution toward its host. Viruses. 2020;12(10):1132.
Article
Google Scholar
Herridge WP, Shibu P, O’Shea J, Brook TC, Hoyles L. Bacteriophages of Klebsiella spp., their diversity and potential therapeutic uses. J Med Microbiol. 2020;69(2):176–94.
CAS
Google Scholar
Shield CG, Swift BMC, McHugh TD, Dedrick RM, Hatfull GF, Satta G. Application of bacteriophages for mycobacterial infections, from diagnosis to treatment. Microorganisms. 2021;9(11):2366.
Article
CAS
Google Scholar
Beinhauerova M, Slana I. Phage amplification assay for detection of mycobacterial infection: a review. Microorganisms. 2021;9(2):237.
Article
CAS
Google Scholar
Puiu M, Julius C. Bacteriophage gene products as potential antimicrobials against tuberculosis. Biochem Soc Trans. 2019;47(3):847–60.
Article
CAS
Google Scholar
Roach DR, Leung CY, Henry M, Morello E, Singh D, Di Santo JP, et al. Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen. Cell Host Microbe. 2017;22(1):38-47.e4.
Article
CAS
Google Scholar
Sula L, Sulová J, Stolcpartová M. Therapy of experimental tuberculosis in guinea pigs with mycobacterial phages DS-6A, GR-21 T, My-327. Czech Med. 1981;4(4):209–14.
CAS
Google Scholar
Nieth A, Verseux C, Barnert S, Süss R, Römer W. A first step toward liposome-mediated intracellular bacteriophage therapy. Expert Opin Drug Deliv. 2015;12(9):1411–24.
Article
Google Scholar
Caratenuto RA, Ciabattoni GO, DesGranges NJ, Drost CL, Gao L, Gipson B, et al. Genome sequences of six cluster N mycobacteriophages, Kevin1, Nenae, Parmesanjohn, ShrimpFriedEgg, Smurph, and SpongeBob, isolated on Mycobacterium smegmatis mc2 155. Microbiol Resour Announc. 2019;8(22): e00399-19.
Article
Google Scholar
Russell DA, Hatfull GF. PhagesDB: the actinobacteriophage database. Bioinformatics. 2017;33(5):784–6.
Article
CAS
Google Scholar
Sweeney KA, Dao DN, Goldberg MF, Hsu T, Venkataswamy MM, Henao-Tamayo M, et al. A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis. Nat Med. 2011;17(10):1261–8.
Article
CAS
Google Scholar
Singla S, Harjai K, Katare OP, Chhibber S. Encapsulation of bacteriophage in liposome accentuates its entry in to macrophage and shields it from neutralizing antibodies. PLoS ONE. 2016;11(4): e0153777.
Article
Google Scholar
Pires DP, Costa AR, Pinto G, Meneses L, Azeredo J. Current challenges and future opportunities of phage therapy. FEMS Microbiol Rev. 2020;44(6):684–700.
Article
CAS
Google Scholar
Pereira C, Costa P, Duarte J, Balcão VM, Almeida A. Phage therapy as a potential approach in the biocontrol of pathogenic bacteria associated with shellfish consumption. Int J Food Microbiol. 2021;338: 108995.
Article
CAS
Google Scholar
Shen Y, Loessner MJ. Beyond antibacterials—exploring bacteriophages as antivirulence agents. Curr Opin Biotechnol. 2021;68:166–73.
Article
CAS
Google Scholar
Brabban AD, Hite E, Callaway TR. Evolution of foodborne pathogens via temperate bacteriophage-mediated gene transfer. Foodborne Pathog Dis. 2005;2(4):287–303.
Article
CAS
Google Scholar
Haaber J, Leisner JJ, Cohn MT, Catalan-Moreno A, Nielsen JB, Westh H, et al. Bacterial viruses enable their host to acquire antibiotic resistance genes from neighbouring cells. Nat Commun. 2016;7(1):13333.
Article
CAS
Google Scholar
Catalão MJ, Filipe SR, Pimentel M. Revisiting anti-tuberculosis therapeutic strategies that target the peptidoglycan structure and synthesis. Front Microbiol. 2019;11(10):190.
Article
Google Scholar
Yang Y, Liu Z, He X, Yang J, Wu J, Yang H, et al. A small mycobacteriophage-derived peptide and its improved isomer restrict mycobacterial infection via dual mycobactericidal-immunoregulatory activities. J Biol Chem. 2019;294(19):7615–31.
Article
CAS
Google Scholar
Wetzel KS, Guerrero-Bustamante CA, Dedrick RM, Ko CC, Freeman KG, Aull HG, et al. CRISPY-BRED and CRISPY-BRIP: efficient bacteriophage engineering. Sci Rep. 2021;11(1):6796.
Article
CAS
Google Scholar
Kalapala YC, Sharma PR, Agarwal R. Antimycobacterial potential of mycobacteriophage under disease-mimicking conditions. Front Microbiol. 2020;14(11): 583661.
Article
Google Scholar
Jamal M, Bukhari SMAUS, Andleeb S, Ali M, Raza S, Nawaz MA, et al. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields. J Basic Microbiol. 2019;59(2):123–33.
Article
Google Scholar
Krut O, Bekeredjian-Ding I. Contribution of the immune response to phage therapy. JI. 2018;200(9):3037–44.
CAS
Google Scholar
Aslam B, Arshad MI, Aslam MA, Muzammil S, Siddique AB, Yasmeen N, et al. Bacteriophage proteome: insights and potentials of an alternate to antibiotics. Infect Dis Ther. 2021;10(3):1171–93.
Article
Google Scholar
Eniyan K, Sinha A, Ahmad S, Bajpai U. Functional characterization of the endolysins derived from mycobacteriophage PDRPxv. World J Microbiol Biotechnol. 2020;36(6):83.
Article
CAS
Google Scholar
Pelfrene E, Willebrand E, CavaleiroSanches A, Sebris Z, Cavaleri M. Bacteriophage therapy: a regulatory perspective. J Antimicrob Chemother. 2016;71(8):2071–4.
Article
Google Scholar
Luong T, Salabarria AC, Edwards RA, Roach DR. Standardized bacteriophage purification for personalized phage therapy. Nat Protoc. 2020;15(9):2867–90.
Article
CAS
Google Scholar
Abedon S, Danis-Wlodarczyk K, Alves D. Phage therapy in the 21st century: is there modern, clinical evidence of phage-mediated efficacy? Pharmaceuticals. 2021;14(11):1157.
Article
Google Scholar
Foglizzo V, Marchiò S. Bacteriophages as therapeutic and diagnostic vehicles in cancer. Pharmaceuticals. 2021;14(2):161.
Article
CAS
Google Scholar
Abedon ST, Danis-Wlodarczyk KM, Wozniak DJ. Phage cocktail development for bacteriophage therapy: toward improving spectrum of activity breadth and depth. Pharmaceuticals. 2021;14(10):1019.
Article
Google Scholar
Abdelrahman F, Easwaran M, Daramola OI, Ragab S, Lynch S, Oduselu TJ, et al. Phage-encoded endolysins. Antibiotics. 2021;10(2):124.
Article
CAS
Google Scholar